| Bioactivity | Globomycin derivative G2A (Compound G2A) is an inhibitor for lipoprotein signal peptidase II (LspA), with an IC50 of 604 nM. Globomycin derivative G2A inhibits E. coli, P. aeruginosa and A. baumannii, with MIC ranging from 12.5 to 32 μg/mL[1]. |
| Formula | C34H62N6O8 |
| Molar Mass | 682.89 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Craven TW, et al., Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase. ACS Chem Biol. 2024 May 17;19(5):1125-1130. |
Globomycin derivative G2A
CAS: F: C34H62N6O8 W: 682.89
Globomycin derivative G2A (Compound G2A) is an inhibitor for lipoprotein signal peptidase II (LspA), with an IC50 of 604
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.